Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial-Reference-Cited by-同舟云学术

Targeting SAMHD1 with hydroxyurea in first‐line cytarabine‐based therapy of newly diagnosed acute myeloid leukaemia: Results from the HEAT‐AML trial

Published:2022-08-18 Issue:6 Volume:292 Page:925-940
ISSN:0954-6820
Container-title:Journal of Internal Medicine
language:en
Short-container-title:J Intern Med

Author:

Jädersten Martin¹²,Lilienthal Ingrid³,Tsesmetzis Nikolaos³,Lourda Magda³⁴,Bengtzén Sofia²,Bohlin Anna²,Arnroth Cornelia⁵,Erkers Tom⁵,Seashore‐Ludlow Brinton⁵,Giraud Géraldine⁶⁷,Barkhordar Giti S.⁸,Tao Sijia⁹,Fogelstrand Linda¹⁰¹¹,Saft Leonie¹²¹³,Östling Päivi⁵,Schinazi Raymond F.⁹,Kim Baek⁹,Schaller Torsten¹⁴,Juliusson Gunnar¹⁵¹⁶,Deneberg Stefan¹²,Lehmann Sören²¹⁷,Rassidakis Georgios Z.¹²¹³,Höglund Martin¹⁷,Henter Jan‐Inge³¹⁸,Herold Nikolas³¹⁸

Affiliation:

1. Department of Hematology Karolinska University Hospital Stockholm Sweden

2. Center for Hematology and Regenerative Medicine Department of Medicine, Karolinska Institutet Stockholm Sweden

3. Childhood Cancer Research Unit Department of Women's and Children's Health Karolinska Institutet Stockholm Sweden

4. Center for Infectious Medicine Department of Medicine Huddinge Karolinska Institutet Karolinska University Hospital Stockholm Sweden

5. Science for Life Laboratory Department of Oncology‐Pathology Karolinska Institutet Stockholm Sweden

6. Department of Immunology, Genetics and Pathology Rudbeck Laboratory Uppsala University Uppsala Sweden

7. Department of Pediatric Oncology Akademiska Children's Hospital Uppsala University Hospital Uppsala Sweden

8. Department of Clinical Genetics and Genomics Sahlgrenska University Hospital Gothenburg Sweden

9. Department of Pediatrics School of Medicine Emory University Atlanta Georgia USA

10. Department of Clinical Chemistry Sahlgrenska University Hospital Gothenburg Sweden

11. Department of Laboratory Medicine Institute of Biomedicine Sahlgrenska Academy at University of Gothenburg Gothenburg Sweden

12. Department of Oncology and Pathology Karolinska Institutet Stockholm Sweden

13. Department of Clinical Pathology and Cancer Diagnostics Karolinska University Hospital Stockholm Sweden

14. Department of Infectious Diseases University Hospital Heidelberg Heidelberg Germany

15. Department of Hematology Skåne University Hospital Lund Sweden

16. Stem Cell Center Department of Hematology Department of Laboratory Medicine Lund University Lund Sweden

17. Department of Medical Sciences Uppsala University Uppsala Sweden

18. Department of Paediatric Oncology Astrid Lindgren Children's Hospital Karolinska University Hospital Stockholm Sweden

Funder

Barncancerfonden

Vetenskapsrådet

National Institutes of Health

Cancerfonden

Jeanssons Stiftelser

Sjöbergstiftelsen

Radiumhemmets Forskningsfonder

Svenska Läkaresällskapet

Publisher

Wiley

Subject

Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/joim.13553

Reference52 articles.

1. Acute leukemia incidence and patient survival among children and adults in the United States, 2001-2007

2. Age and acute myeloid leukemia: real world data on decision to treat and outcomes from the Swedish Acute Leukemia Registry

3. Older Patients With Acute Myeloid Leukemia Benefit From Intensive Chemotherapy: An Update From the Swedish Acute Leukemia Registry

4. Diagnosis and management of AML in adults: 2017 ELN recommendations from an international expert panel

5. Anthracycline Dose Intensification in Acute Myeloid Leukemia

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1 via a comprehensive screening funnel;iScience;2024-02

2. Allosteric substrate activation of SAMHD1 shapes deoxynucleotide triphosphate imbalances by interconnecting the depletion and biosynthesis of different dNTPs;2023-11-14

3. Hypomethylating agents plus modified priming regimens compared with venetoclax-based regimens based on molecular characteristics for newly diagnosed patients with acute myeloid leukemia: a multi-center cohort study;Annals of Hematology;2023-09-18

4. Nucleoside-based anticancer drugs: Mechanism of action and drug resistance;Biochemical Pharmacology;2023-09

5. Identification and evaluation of small-molecule inhibitors against the dNTPase SAMHD1viaa comprehensive screening funnel;2023-01-18